{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:47:51Z","timestamp":1793364471418,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to compare treatment strategies and survival of patients with synchronous colorectal peritoneal metastases (CPM) and patients with metachronous CPM in a nationwide cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All patients from the Netherlands Cancer Registry with synchronous or metachronous CPM whose primary colorectal cancer (CRC) was diagnosed between 1 January and 30 June 2015 were included in the study. Treatments were categorized as (A) cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [CRS-HIPEC]; (B) palliative treatment; or (C) best supportive care. Overall survival (OS) for all the patients and disease-free survival (DFS) for those who underwent CRS-HIPEC were compared between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 7233 patients, 743 had a diagnosis of CPM, including 409 patients with synchronous CPM and 334 patients with metachronous CPM. The median OS was 8.1 months for the patients with synchronous CPM versus 12 months for the patients with metachronous CPM (<jats:italic>p<\/jats:italic> = 0.003). After multivariable correction, OS no longer differed between the patients with synchronous CPM and those with metachronous CPM (HR 1.03 [0.83\u20131.27])<jats:italic>.<\/jats:italic> The patients with metachronous CPM more often underwent CRS-HIPEC than the patients with synchronous CPM (16 % vs 8 %; <jats:italic>p<\/jats:italic> = 0.001). The two groups did not differ statistically in terms of DFS and OS (median DFS, 21.5 vs 14.1 months, respectively;<jats:italic> p<\/jats:italic> = 0.094; median OS, 37.8 vs. 35.8 months, respectively;<jats:italic> p<\/jats:italic> = 0.553).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This population-based study showed that survival for the patients with synchronous CPM and patients with metachronous CPM did not significantly\u00a0differ. This suggests that a similar prognosis may be expected for patients selected for treatment regardless of the onset of CPM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-021-10190-z","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T14:34:38Z","timestamp":1622644478000},"page":"9073-9083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study"],"prefix":"10.1245","volume":"28","author":[{"given":"C.","family":"Bakkers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2692-0994","authenticated-orcid":false,"given":"R. J.","family":"Lurvink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. W.","family":"Nienhuijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. F.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"Creemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. E.","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. N.","family":"van Erning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. H.","family":"De Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"key":"10190_CR1","unstructured":"World Health Organisation Global Cancer Observatory. https:\/\/gco.iarc.fr\/today\/home. Accessed 1 Jan 2021."},{"key":"10190_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.11.135","author":"RJ Lurvink","year":"2020","unstructured":"Lurvink RJ, Bakkers C, Rijken A, et al. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study. Eur J Surg Oncol. 2020. https:\/\/doi.org\/10.1016\/j.ejso.2020.11.135.","journal-title":"Eur J Surg Oncol."},{"key":"10190_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2014.04.004","author":"YRBM van Gestel","year":"2014","unstructured":"van Gestel YRBM, de Hingh IHJT, van Herk-Sukel MPP, et al. Patterns of metachronous metastases after curative treatment of colorectal cancer. Cancer Epidemiol. 2014. https:\/\/doi.org\/10.1016\/j.canep.2014.04.004.","journal-title":"Cancer Epidemiol."},{"key":"10190_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-015-9719-0","author":"LGM van der Geest","year":"2015","unstructured":"van der Geest LGM, Lam-Boer J, Koopman M, Verhoef C, Elferink MAG, de Wilt JHW. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015. https:\/\/doi.org\/10.1007\/s10585-015-9719-0.","journal-title":"Clin Exp Metastasis."},{"key":"10190_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-020-1784-4","author":"JSM Wong","year":"2020","unstructured":"Wong JSM, Tan GHC, Chia CS, Ong J, Ng WY, Teo MCC. The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2020. https:\/\/doi.org\/10.1186\/s12957-020-1784-4.","journal-title":"World J Surg Oncol."},{"key":"10190_CR6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2002.02274.x","author":"DG Jayne","year":"2002","unstructured":"Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002. https:\/\/doi.org\/10.1046\/j.1365-2168.2002.02274.x.","journal-title":"Br J Surg."},{"key":"10190_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.09.035","author":"A Sommariva","year":"2020","unstructured":"Sommariva A, Ansaloni L, Baiocchi GL, et al. Diagnostic and therapeutic algorithm for colorectal peritoneal metastases: a consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology. Eur J Surg Oncol. 2020. https:\/\/doi.org\/10.1016\/j.ejso.2020.09.035.","journal-title":"Eur J Surg Oncol."},{"key":"10190_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.07.003","author":"M Bushati","year":"2018","unstructured":"Bushati M, Rovers KP, Sommariva A, et al. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2018. https:\/\/doi.org\/10.1016\/j.ejso.2018.07.003.","journal-title":"Eur J Surg Oncol."},{"key":"10190_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/codi.13593","volume":"19","author":"CEL Klaver","year":"2017","unstructured":"Klaver CEL, Groenen H, Morton DG, Laurberg S, Bemelman WA, Tanis PJ. Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines. Color Dis. 2017;19:224\u201336. https:\/\/doi.org\/10.1111\/codi.13593.","journal-title":"Color Dis."},{"key":"10190_CR10","unstructured":"Landelijke Werkgroep Gastro Intestinale Tumoren. Richtlijn colorectaal carcinoom Versie 3.0. https:\/\/www.nhg.org\/sites\/default\/files\/content\/nhg_org\/uploads\/colorectaalcarcinoom.pdf. Accessed 1 Jan 2021."},{"key":"10190_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds236","author":"HJ Schmoll","year":"2012","unstructured":"Schmoll HJ, Van Cutsem E, Stein A, et al. Esmo consensus guidelines for management of patients with colon and rectal cancer: a personalized approach to clinical decision-making. Ann Oncol. 2012. https:\/\/doi.org\/10.1093\/annonc\/mds236.","journal-title":"Ann Oncol."},{"key":"10190_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5545-0","author":"KP Rovers","year":"2019","unstructured":"Rovers KP, Bakkers C, Simkens GAAM, et al. Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, random. BMC Cancer. 2019. https:\/\/doi.org\/10.1186\/s12885-019-5545-0.","journal-title":"BMC Cancer."},{"key":"10190_CR13","doi-asserted-by":"publisher","unstructured":"Van Cutsem E, Cervantes A, Nordlinger B, Arnold D, The ESMO Guidelines Working Group. Metastatic colorectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014. doi:https:\/\/doi.org\/10.1093\/annonc\/mdu260.","DOI":"10.1093\/annonc\/mdu260"},{"key":"10190_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21169","author":"JOW Pelz","year":"2009","unstructured":"Pelz JOW, Stojadinovic A, Nissan A, Hohenberger W, Esquivel J. Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis. J Surg Oncol. 2009. https:\/\/doi.org\/10.1002\/jso.21169.","journal-title":"J Surg Oncol."},{"key":"10190_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.12.034","author":"KP Rovers","year":"2017","unstructured":"Rovers KP, Simkens GA, Vissers PA, et al. Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: a nationwide population-based study. Eur J Cancer. 2017. https:\/\/doi.org\/10.1016\/j.ejca.2016.12.034.","journal-title":"Eur J Cancer."},{"key":"10190_CR16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07294-y","author":"JEKR Hentzen","year":"2019","unstructured":"Hentzen JEKR, Rovers KP, Kuipers H, et al. Impact of synchronous versus metachronous onset of colorectal peritoneal metastases on survival outcomes after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a multicenter, retrospective, observational study. Ann Surg Oncol. 2019. https:\/\/doi.org\/10.1245\/s10434-019-07294-y.","journal-title":"Ann Surg Oncol."},{"key":"10190_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25596","author":"VE Lemmens","year":"2011","unstructured":"Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JWW, De Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011. https:\/\/doi.org\/10.1002\/ijc.25596.","journal-title":"Int J Cancer."},{"key":"10190_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.10.001","author":"YRBM Van Gestel","year":"2014","unstructured":"Van Gestel YRBM, Thomassen I, Lemmens VEPP, et al. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer. Eur J Surg Oncol. 2014. https:\/\/doi.org\/10.1016\/j.ejso.2013.10.001.","journal-title":"Eur J Surg Oncol."},{"key":"10190_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002200.pub4","author":"M Jeffery","year":"2019","unstructured":"Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2019. https:\/\/doi.org\/10.1002\/14651858.CD002200.pub4.","journal-title":"Cochrane Database Syst Rev."},{"key":"10190_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10233","author":"S Mokhles","year":"2016","unstructured":"Mokhles S, Macbeth F, Farewell V, et al. Meta-analysis of colorectal cancer follow-up after potentially curative resection. Br J Surg. 2016. https:\/\/doi.org\/10.1002\/bjs.10233.","journal-title":"Br J Surg."},{"key":"10190_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.199","author":"EP Van Der Stok","year":"2017","unstructured":"Van Der Stok EP, Spaander MCW, Gr\u00fcnhagen DJ, Verhoef C, Kuipers EJ. Surveillance after curative treatment for colorectal cancer. Nat Rev Clin Oncol. 2017. https:\/\/doi.org\/10.1038\/nrclinonc.2016.199.","journal-title":"Nat Rev Clin Oncol."},{"key":"10190_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2015.06.008","author":"CJ Verberne","year":"2015","unstructured":"Verberne CJ, Zhan Z, Van Den Heuvel E, et al. Intensified follow-up in colorectal cancer patients using frequent carcino-embryonic antigen (CEA) measurements and CEA-triggered imaging: results of the randomized \u201cCEAwatch\u201d trial. Eur J Surg Oncol. 2015. https:\/\/doi.org\/10.1016\/j.ejso.2015.06.008.","journal-title":"Eur J Surg Oncol."},{"key":"10190_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10535","author":"CJ Verberne","year":"2017","unstructured":"Verberne CJ, Zhan Z, van den Heuvel ER, et al. Survival analysis of the CEAwatch multicentre clustered randomized trial. Br J Surg. 2017. https:\/\/doi.org\/10.1002\/bjs.10535.","journal-title":"Br J Surg."},{"key":"10190_CR24","doi-asserted-by":"publisher","unstructured":"Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010. https:\/\/doi.org\/10.1200\/JCO.2010.29.0163.","DOI":"10.1200\/JCO.2010.29.0163"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10190-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-021-10190-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-021-10190-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T15:03:10Z","timestamp":1636902190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-021-10190-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":24,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10190"],"URL":"https:\/\/doi.org\/10.1245\/s10434-021-10190-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,2]]},"assertion":[{"value":"12 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I. H. De Hingh reports an unrestricted research grant from RanD\/QPS and Roche paid to the institute outside the submitted work. The remaining authors have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}